These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 960063)

  • 1. Intravenous arachidonate in the mouse: a model for the evaluation of antithrombotic drugs.
    Kohler C; Wooding W; Ellenbogen L
    Thromb Res; 1976 Jul; 9(1):67-80. PubMed ID: 960063
    [No Abstract]   [Full Text] [Related]  

  • 2. Prostacyclin (PGI2) and thromboxane A2 interaction in vivo. Regulation by aspirin and relationship with anti-thrombotic therapy.
    Korbut R; Moncada S
    Thromb Res; 1978 Sep; 13(3):489-500. PubMed ID: 369028
    [No Abstract]   [Full Text] [Related]  

  • 3. [Induction of pulmonary thrombosis in mice, rabbits and hamsters by intravenous injection of arachidonic acid. Comparative study of 3 experimental models in vivo and the antithrombotic activity of triflusal].
    García Rafanell J; Bellés L; Forn J
    Arch Farmacol Toxicol; 1979 Dec; 5(3):193-8. PubMed ID: 546338
    [No Abstract]   [Full Text] [Related]  

  • 4. Sex differences in mouse platelet aggregation.
    Torres Duarte AP; Ramwell P; Myers A
    Thromb Res; 1986 Jul; 43(1):33-9. PubMed ID: 3088759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous arachidonate-induced respiratory distress: comparative study of three in vivo models for the measurement of antithrombotic activity.
    Garcia Rafanell J; Forn J
    J Pharmacol Methods; 1982 May; 7(3):231-8. PubMed ID: 6810027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Letter: Arachidonic acid and platelet aggregation.
    Furlow TW
    Lancet; 1974 Nov; 2(7888):1080. PubMed ID: 4138267
    [No Abstract]   [Full Text] [Related]  

  • 7. Inhibition of platelet aggregation by a new agent, 2,2'-dithiobis-(N-2-hydroxypropyl benzamide) (KF4939).
    Yamada K; Shuto K; Nakamizo N
    Thromb Res; 1983 Jan; 29(2):197-206. PubMed ID: 6405499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between inhibitory effect on platelet aggregation and disposition of sulfinpyrazone and its metabolites in rabbits. Part I: Single dose study.
    Ritschel WA; Kuo BS
    Biopharm Drug Dispos; 1987; 8(1):1-9. PubMed ID: 3107626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of indomethacin and sulfinpyrazone on in vivo formation of thromboxane B2 and prostaglandin D2 during arachidonate infusion in rabbits.
    Cerskus AL; Ali M; Zamecnik J; McDonald JW
    Thromb Res; 1978 Mar; 12(3):549-53. PubMed ID: 653641
    [No Abstract]   [Full Text] [Related]  

  • 10. Opposite effect of lysine on platelet aggregation induced by arachidonate and by other aggregants.
    Ts'ao C; Hart SJ; Krajewski DV; Sorensen PG
    Thromb Haemost; 1982 Aug; 48(1):78-83. PubMed ID: 6813998
    [No Abstract]   [Full Text] [Related]  

  • 11. Antithrombotic effects of KP-10614, a novel and stable prostacyclin (PGI2) analog.
    Kanayama T; Kimura Y; Iseki K; Hayashi Y; Tamao Y; Mizogami S
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1210-7. PubMed ID: 1702154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-tocopherol: its inhibition on human platelet aggregation.
    Fong JS
    Experientia; 1976 May; 32(5):639-41. PubMed ID: 1278322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antithrombotic action of benzydamine].
    Jansen JW
    Arzneimittelforschung; 1987 May; 37(5A):626-8. PubMed ID: 3619983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating platelet aggregates and thrombocytopenia induced by intravenous infusions of arachidonic and lauric acids in guinea pigs.
    Rafflenbeul D; Zbinden G
    Acta Haematol; 1977; 57(2):87-95. PubMed ID: 402770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A study of intravascular platelet aggregation by continuous platelet counting.
    Smith GM; Duncan GG
    Thromb Res; 1981 Aug; 23(3):275-88. PubMed ID: 6795759
    [No Abstract]   [Full Text] [Related]  

  • 16. Synergism between platelet aggregating agents: the role of the arachidonate pathway.
    Kinlough-Rathbone RL; Packham MA; Mustard JF
    Thromb Res; 1977 Nov; 11(5):567-80. PubMed ID: 337565
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of the new antiplatelet agent 2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine on platelet aggregation and thrombosis in experimental animals.
    Momo K; Someya K; Tachiiri T; Mitsuoka Y; Nakamura K; Imai S; Ino T; Ohkubo H
    Arzneimittelforschung; 1992 Jan; 42(1):32-9. PubMed ID: 1586377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired metabolism of arachidonate in selenium deficient animals.
    Masukawa T; Goto J; Iwata H
    Experientia; 1983 Apr; 39(4):405-6. PubMed ID: 6403377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of TEI-2117, a new antithrombotic compound, on arachidonic acid metabolism].
    Otsu A; Hoshina K; Kurozumi S; Hashimoto Y; Ishimoto S
    Rinsho Byori; 1979; Suppl 40():117-21. PubMed ID: 551219
    [No Abstract]   [Full Text] [Related]  

  • 20. Arachidonate-induced thrombosis in mice: effects of gender or testosterone and estradiol administration.
    Uzunova AD; Ramey ER; Ramwell PW
    Prostaglandins; 1977 May; 13(5):995-1002. PubMed ID: 866707
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.